Leavitt Chase C. — SEC insider filings

SEC reporting owner CIK 1777467. 15 insider filings on record with FilingPulse; latest filed 2026-09-15.

Transaction summary — filings shown

Covers all 15 filings on record, filed 2021-03-17 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Mobia Medical, Inc. (MOBI)SEE REMARKS22 legs · 5,000 sh · $65,600—1
Oncternal Therapeutics, Inc. (ONCT)General Counsel/Secretary125 legs · 40,000 sh · $38,705—18
Lineage Cell Therapeutics, Inc. (LCTX)General Counsel/Secretary1——1

Insider filings — Leavitt Chase C.

FiledFormIssuerReported transactionsSource
2026-09-154Mobia Medical, Inc. (MOBI)Purchase (P): 2,000 @ $10.30EDGAR
2026-05-114Mobia Medical, Inc. (MOBI)Purchase (P): 3,000 @ $15 · Grant/award (A): 175,760 (derivative) @ $0EDGAR
2024-02-154Oncternal Therapeutics, Inc. (ONCT)Grant/award (A): 14,200 (derivative) @ $0EDGAR
2024-01-054Oncternal Therapeutics, Inc. (ONCT)Tax withholding (F): 11,838 @ $0.50EDGAR
2023-10-044Oncternal Therapeutics, Inc. (ONCT)Disposition to issuer (D): 65,000 (derivative) · Disposition to issuer (D): 55,519 (derivative) · Disposition to issuer (D): 28,750 (derivative) · Disposition to issuer (D): 210,000 (derivative) · Grant/award (A): 65,000 (derivative) · Grant/award (A): 55,519 (derivative) · +3 moreEDGAR
2023-07-054Oncternal Therapeutics, Inc. (ONCT)Tax withholding (F): 10,305 @ $0.36EDGAR
2023-04-144Oncternal Therapeutics, Inc. (ONCT)Purchase (P): 15,000 @ $0.29 · Purchase (P): 10,000 @ $0.29EDGAR
2023-02-234Oncternal Therapeutics, Inc. (ONCT)Grant/award (A): 210,000 (derivative) @ $0EDGAR
2023-01-054Oncternal Therapeutics, Inc. (ONCT)Tax withholding (F): 6,091 @ $1.02EDGAR
2022-08-014Oncternal Therapeutics, Inc. (ONCT)Grant/award (A): 43,125 @ $0 · Grant/award (A): 28,750 (derivative) @ $0EDGAR
2022-01-314Oncternal Therapeutics, Inc. (ONCT)Purchase (P): 8,500 @ $1.78 · Purchase (P): 5,000 @ $1.63EDGAR
2022-01-244Oncternal Therapeutics, Inc. (ONCT)Grant/award (A): 55,519 (derivative) @ $0EDGAR
2022-01-054Oncternal Therapeutics, Inc. (ONCT)Grant/award (A): 29,867 @ $0EDGAR
2021-06-154Oncternal Therapeutics, Inc. (ONCT)Purchase (P): 1,500 @ $5.45EDGAR
2021-03-174Lineage Cell Therapeutics, Inc. (LCTX)Grant/award (A): 699,100 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-03-15 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1777467 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs